Blood Sugar and GLUT1 Protein May Be Biomarkers for Ovarian Cancer, Study Finds

Blood Sugar and GLUT1 Protein May Be Biomarkers for Ovarian Cancer, Study Finds
Researchers studying blood glucose levels and the glucose transporter protein GLUT1 have discovered a potential biomarker for aggressive ovarian cancer. A study found that patients with lower blood glucose levels had increased GLUT1 expression in their ovarian tumor cells, prompting the need for further study of glucose metabolism in ovarian cancer. The study titled, “GLUT1

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *